mide and four months' treatment with isoniazid and
Introduction treatment after return. Those who have missed more The Botswana national tuberculosis programme is than 22 days but less than 43 days of treatment by six unique in both its approach and its implementation. months are regarded as irregular attenders and given Short course chemotherapy is given to all patients who an additional six weeks' treatment when traced. have tuberculosis diagnosed and treatment is super-Patients who have missed 21 days oftreatment or less at vised daily for the entire six months. This approach has six months are regarded as having completed treatachieved high compliance rates. The successes can be ment. attributed to intensive repeated health education, District tuberculosis coordinators check treatment commitment of health workers, well developed health cards for all patients in their districts monthly, compile infrastructure, and integration of the programme into the statistics, and calculate compliance of patients. the primary health care structure.
Reports are received at the national centre from all Developing countries often have difficulty imple-districts every quarter. Data are analysed by the menting the tuberculosis case finding and case holding quarterly cohort analysis system and compliance calcucomponents of their programmes.'`3 This paper illus-lated as the total number of days attended for all trates the success of daily supervised treatment of all patients receiving treatment divided by the total patients with tuberculosis in Botswana with short number of days expected for treatment Education of health workers and the community on tuberculosis has been incorporated into in service training programmes, which occur at least two to three times a year in each district. At the national level seminars and workshops are held every six months to update district tuberculosis coordinators on the latest advances and methods of preventing and controlling tuberculosis.
Case holding has been one of the main successes of the Botswana tuberculosis programme. This can be attributed to introduction of short course chemotherapy, good health infrastructure, integration of the programme into primary health care system, and vigorous health education. The costs of providing short course chemotherapy and daily supervised treatment to all patients needs to be evaluated. Further study of the epidemiology of tuberculosis is also needed in view of the well established interaction between tuberculosis and HIV worldwide.
kChildhood cancer, intramuscular vitamin K, and pethidine given during labour / Jean'olding, Rosemaryereenwood, Karen Pirmingham, Martin tott Abstract Objective-To assess unexpected associations between childhood cancer and pethidine given in labour and the neonatal administration of vitamin K that had emerged in a study performed in the 1970 national birth cohort.
Design and setting-195 children with cancer diagnosed in 1971-March 1991 and born in the two major Bristol maternity hospitals in 1965-87 were compared with 558 controls identified from the delivery books for the use of pethidine during labour and administration of vitamin K.
Main outcome measures-Odds ratios for cancer in the presence of administration of pethidine or of intramuscular vitamin K. Both logistic regression and Mantel-Haenszel techniques were used for statistical analyses.
Results-Children of mothers given pethidine in labour were not at increased risk of cancer (odds ratio 1-05, 95% confidence interval 0*7 to 1.5) after allowing for year and hospital of delivery, but there was a significant association (p=0002) with intramuscular vitamin K (odds ratio 1-97, 95% confidence interval 1*3 to 3.0) when compared with oral vitamin K or no vitamin K. There was no significantly increased risk for children who had been given oral vitamin K when compared with no vitamin K (odds ratio 1 15, 95% confidence interval 0 5 to 2 7). These results could not be accounted for by other factors associated with administration of intramuscular vitamin K, such as type of delivery or admission to a special care baby unit.
Conclusions-The only two studies so far to have examined the relation between childhood cancer and intramuscular vitamin K have shown similar results, and the relation is biologicaily plausible. The prophylactic benefits against haemorrhagic disease are unlikely to exceed the potential adverse effects from intramuscular vitamin K. Since oral vitamin K has major benefits but no obvious adverse effects this could be the prophylaxis of choice.
Introduction
Most studies of the factors acting in fetal or early life that are relevant to childhood cancer have been, for obvious reasons, case-control and retrospective in design.' Retrospective studies have the advantage that large numbers of affected subjects may be covered, but they can also be subject to biases such as differential recall between cases and controls of events often long since past. It is therefore important to test the findings wherever possible by prospective studies.
Information collected prospectively on a nationally representative sample of pregnancies delivered in 1970 was examined to assess potential factors associated with subsequent cancer in childhood. 5 
